Brought to you by 
Stereotaxis completes $44mm IPO
08 Sep 2004
Executive Summary
Three months after its IPO filing, Stereotaxis (cardiology instrument control systems) has completed its offering on Nasdaq, netting $44.4mm (including a 460k overallotment) through the sale of 5.9mm shares at $8 apiece. It had originally hoped to raise up to $115mm by selling a million more shares priced in the $14-16 range.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com